GOVX (geovax.com) Bozor qiymatining balans qiymatiga nisbati
GeoVax Labs, Inc. (GOVX) saraton va xavfli viruslarga qarshi kurashish uchun ilg'or vaksinalar va immunoterapiya usullarini ishlab chiqadi hamda klinik xatarlarni kamaytirish uchun o'z ishlanmalar portfelini diversifikatsiya qilmoqda. Ushbu grafik 0.83 aktiv qiymatini aks ettiradi, bunda biznes NIH va Pentagon bilan hamkorlikka tayanadi. Biroq, daromadning yo'qligi FDA tasdig'i olinguniga qadar kompaniyani narxlarni belgilash imkoniyatidan mahrum qiladi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_GOVX_-_GeoVax-Labs-Inc._-_Market-Capitalization-to-Net-Assets "GOVX GeoVax Corp Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
GeoVax Labs (GOVX) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati GeoVax Labs, Inc.|GOVX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati GeoVax Labs Inc|GOVX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar GeoVax Labs Inc|GOVX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari GeoVax
Kompaniyaning dastlabki tahlili:GeoVax Labs, Inc. - GOVX
GeoVax Labs, Inc. (GOVX) immunoterapiya vaksinalari va onkologik dori vositalarini ishlab chiqishning yuqori xavfli sektorida faoliyat yuritadi. Buxgalteriya qiymatiga nisbatan narx koeffitsiyentini tahlil qilish orqali investor kompaniyaning bozor qiymati va uning sof aktivlari o'rtasidagi bog'liqlikni baholaydi. Ushbu ko'rsatkich buxgalteriya qiymatidan yuqori bozor premiumini o'lchaydi va fundamental baholashning tiklanish sur'atini belgilaydi. Diversifikatsiyalashgan tadqiqotlar portfeli klinik muvaffaqiyatsizliklar yuz bergan taqdirda kapitalning yo'qolish xavfini kamaytiradi, bu esa biznesning barqarorligini va aktivlarining real qiymatini tasdiqlaydi.
Asosiy raqobatchilar
Kapitallashuvning sof aktivlarga nisbati argenx SE|BNTX (biontech.de) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Bozor kapitallashuvining balans qiymatiga nisbati RIGL|ANAB - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATXS|ENGN (engene.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati RAPT (RAPT Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti Aerovate (JBIO)|Kapitallashuvning sof aktivlarga nisbati Aclaris (ACRS)|Bozor qiymatining balans qiymatiga nisbati Kyverna Therapeutics, Inc (KYTX)|Bozor kapitallashuvining balans qiymatiga nisbati TLSA (Tiziana Life Sciences)|CABA - Bozor kapitallashuvining balans qiymatiga nisbati|Ventyx Biosciences, Inc. (VTYX) - Kapitallashuvning sof aktivlarga nisbati|Theratechnologies, Inc. (THTX) - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Avalo Therapeutics Inc. AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Agenus|Bozor qiymatining balans qiymatiga nisbati climbbio.com|Bozor kapitallashuvining balans qiymatiga nisbati ZURA|Bozor kapitallashuvining balans qiymatiga nisbati aTyr Pharma Inc (ATYR)|Bozor kapitallashuvining balans qiymatiga nisbati Adagene Inc. ADAG|ImageneBio - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati STTK (Shattuck Therapeutics)|Equillium, Inc. (EQ) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati connectbiopharm.com CNTB|Immunic (IMUX) - Balans qiymatiga nisbatan bozor qiymati|ATRA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IFRX|Bozor qiymatining balans qiymatiga nisbati X4 Pharmaceuticals XFOR|Kapitallashuvning balans qiymatiga nisbati adicetbio.com (ACET)|Celularity - Bozor kapitallashuvining balans qiymatiga nisbati|INMB - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati BRNS (Barinthus Bio)|KZR - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SABS (SAB Biotherapeutics)|AKTX (akaritx.com) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati ENLV (Enlivex Therapeutics Ltd)|Bozor qiymatining balans qiymatiga koeffitsiyenti Q32 Bio Corp (QTTB)|Kapitallashuvning sof aktivlarga nisbati Edesa (EDSA)|Bozor qiymatining balans qiymatiga nisbati iBio Corporation IBIO|CARM - Kapitallashuvning sof aktivlarga nisbati|xtlbio.com - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Bolt Bio|HCWB - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati aptevotherapeutics.com APVO|aimimmuno.com (AIM) - Balans qiymatiga nisbatan bozor qiymati|ADTX (Aditxt Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GRI|XORTX Therapeutics (XRTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HIND (Vyome Holdings Inc.)|Revelation Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Indaptus Corp INDP|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|CalciMedica, Inc. (CALI) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati affimed.com AFMD|Allakos (ALLK) - Balans qiymatiga nisbatan bozor qiymati|HOOK: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati OCEA (oceanbiomedical.com)|TC BioPharm - Bozor qiymatining balans qiymatiga nisbati|THRD - Kapitallashuvning sof aktivlarga nisbati